High permeability pulmonary edema (ARDS) during tocolytic therapy — a case report by Russi, Erich W. et al.
Russi et al, Pulmonary edema during tocolytic therapy 45
J. Perinat. Med.
16 (1988) 45
High permeability pulmonary edema (ARDS) during tocolytic
therapy — a case report*
Erich W. Russi1, Ludwig Spaetling2, J rg Gmiir1, and Henning Schneider2
Department of Internal Medicine1 and Department of Obstetrics2, University
Hospital, Zurich, Switzerland
1 Introduction
The therapeutic value of fenoterol and other pre-
dominantly beta-sympathomimetic agents for the
treatment of premature labor is undisputed [11].
Recently several cases of pulmonary edema have
been reported in patients with beta-sympatho-
mimetic agents alone or in combination with corti-
costeroids [1, 2,4, 8,9,10,12,18]. The mechanism
of the development of pulmonary edema in
women in premature labor and with tocolytic
treatment remains speculative. Our observation
suggests that in some cases increased pulmonary
capillary permeability may be a likely mechanism.
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2 Case report
A 26-year old woman, with 4 interruptions of
pregnancy in her history was admitted because of
premature labor at 30 weeks pregnancy. Her past
medical history was unremarkable and physical
examination was normal. The following values
were recorded for vital signs: blood pressure 100/
60 torr; pulse 84 beats/min; respiration 16 breaths/
min. The chest was clear to auscultation and
percussion and no murmur or gallop rhythm was
noted. ECG was normal. Because of regular con-
tractions persisting four hours after admission
with effacement of the cervix and beginning dilata-
tion of 2 cm a continuous infusion of fenoterol at
a rate of 2 μg/min together with low-dose magne-
sium - sulfate/magnesium - aspartate - hy drochloride
(40 mmol/24 hours) for cardioprotection was
started [17]. There was no oral fluid restriction
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and parenteral fluid was administered at a rate of
60 ml/h.
Furthermore the patient received two intravenous
injections of 12 mg of bethamethasone 12 hours
apart. On the following day spontaneous rupture
of membranes was noticed. Because of a hemoglo-
bin of 9.7 g/100 ml two units of packed red cells
were transfused over a period of 6 hours. At
the end of the transfusion the patient started to
complain about a tight feeling in her chest and
two hours later she became short of breath. The
pulse rate was 96 beats/min the respiratory rate
increased to 40 breaths/min and the patient be-
came slightly cyanotic despite 41/min of oxygen.
The temperature at this point was 37.6 °C, and
the heart rate 140/min. Arterial blood gases while
receiving oxygen at 8 1/min were Ρθ2:33 torr,
Pco2:34.8 torr, and pH:7.41. Tocolytic therapy
was stopped immediately. Chest-x-ray was con-
sistent with alveolar pulmonary edema. Treatment
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with furosemide, digoxin and nitroglycerin was
started but with no significant effect. The total
urine output during the first five hours following
treatment was 570 ml. Because of further deterio-
ration, the patient had to be intubated and venti-
lated. For induction of labor an intravenous infu-
sion of PGEi was started. Because of signs of fetal
distress in the fetal heart rate tracing, a male of
1220 g was delivered by low forceps with an Apgar
score of 2 at l min, 4 at 5 min and 7 at 10 min
with an umbilical artery pH of 7.12.
Three hours after delivery the infant could be
extubated and remained in good condition. After
blood cultures had been obtained treatment with
amoxycillin and gentamicin was started which
could be stopped after 48 hours since cultures
remained negative. Suddenly on the fifth postpar-
tum day the condition of the previously healthy
infant deteriorated with clinical signs of sepsis.
In spite of agressive treatment with antibiotics,
immunoglobulins and mechanical ventilation
there was rapid progression and the infant died
on the sixth day. Blood as well as cerebrospinal
fluid cultures grew klebsiellae suggesting a noso-
comial infection.
In view of early signs of chorioamnionitis the
mother was started on ceftriaxon and she was
transferred to the medical ICU. A Swan-Ganz
catheter was inserted; right atrial pressure was
5 mmHg; right ventricle 25/5 mmHg; pulmonary
artery 25/12 mmHg; wedge pressure 10 mmHg;
cardiac output as measured by thermo-dilution
was 4.4 l/m2/min. The electrocardiogram was nor-
mal. Ventilator settings, arterial blood gas analysis
and total thoracic quasi static compliance (em-
ploying the formula described by BONE [3]) are
summarized in table I. The analysis of the tracheo-
bronchial secretion revealed a protein content of
6.4 g/100ml (plasma: 6.1 g/100ml) with 3.29 g/
PLASMA
TOTAL PROTEIN:
A l b u m i n :
G l o b u l i n s :
6.1 g / d l
2 .9 g / d l
3.2 g / d l
EDEMA FLUID
TOTAL PROTEIN:
A l b u m i n :
G l o b u l i n s :
6.4 g / d l
3.3 g / d l
3.1 g / d l
Figure 1. Protein electrophoresis of plasma and lung
edema fluid.
100ml albumin (plasma: 2.94 g/100ml) (figure 1).
On gram stains no microorganisms were seen and
blood cultures remained sterile.
Table I. Ventilator settings and resulting arterial blood gases.















































FICh: fractional inspiratory oxygen concentration; TV: tidal volume (ml); f: respiration rate (breaths/min); PEEP:
positive endexspiratory pressure (cmtbO); CST: quasi-static compliance (ml/cmthO). *: Torr.
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Serum electrolytes including calcium and magne-
sium, creatinine, blood urea nitrogen und glucose
were normal as well as all coagulation parameters
and there were no signs of increased fibrinolysis.
The hemoglobin was 13.6 g/100 ml, leucocytes
15'500 with 27.5% bands, 55% segments, 0.5%
eosinophilis, 1.0% basophils, 5.0% monocytes
and 11.0% lymphocytes. Because of initial suspi-
cion of sepsis, piperacillin and netromycin were
administered under blood level monitoring. The
patient's respiratory condition improved rapidly
and she was extubated after 36 hours of ventila-
tory support. During this time she had received a
total of 3060 ml of intravenous fluids and her
urine output was 2650 ml. Her chest roentgeno-
gram cleared completely and pulmonary function
analysis eight days later revealed normal static
and dynamic lung volumes. An idiopathic hyper-
trophic aortic stenosis or other cardiac abnormali-
ties were excluded by an echocardiography. The
patient's blood group was 0 Rh positive. The
serum was tested for red cell antibodies and dem-
onstrated negative standard compatibility tests
with red cells of both donors. The patient's serum
and the serum of both donors were further tested
for lymphocyte and granulocyte cytotoxicity (di-
rectly and in white cell panel). All these tests were
negative.
3 Discussion
Fenoterol and other beta-sympathomimetic ag-
ents are widely used for the treatment of prema-
ture labor. These agents increase maternal pulse
rate and cardiac output and cause peripheral vaso-
dilatation. In addition they have an antidiuretic
effect with retention of sodium and water [7].
Although pulmonary edema has been infrequently
reported [1, 2, 4, 8, 9, 10, 12, 18], it is a serious
complication that has even resulted in maternal
death [1]. Since beta-sympathomimetic agents may
further increase the physiologic high output state
of pregnancy it has been speculated that the most
likely cause of pulmonary edema is heart failure
triggered or aggravated by fluid overload [1, 8,
18]. Although chest pain and electrocardiographic
changes consistent with myocardial ischemia have
been reported during terbutaline treatment in
young women with presumably normal coronary
arteries [9] an echocardiographic study demon-
strated increases in left ventricular function para-
meters even in a patient who developed clinically
manifest pulmonary edema [21]. These data sug-
gest that pulmonary edema probably is not due
to left ventricular failure. In most of the reported
cases a positive fluid balance was documented
before the development of pulmonary edema and
the respiratory symptoms would markedly im-
prove after the induction of diuresis so that fluid
overload might play a crucial role as a trigger
[8, 9]. The respiratory distress which developped
under tocolytic therapy in this 26-year old women
apparently was of a different nature and fulfills the
criteria of an adult respiratory distress syndrome
(ARDS). ARDS is commonly defined as a clinical
pathophysiologic condition of sudden onset char-
acterized by progressive dyspnea, severe hypox-
emia which is relatively refractory to high inspira-
tory oxygen concentrations, diffuse pulmonary
infiltrates , and "stiff lungs". It may develop fol-
lowing a variety of acute lung injuries, usually in
persons with no prior lung disease [13]. Of specific
interest to the obstetrician are eclampsia, sepsis,
aspiration and amniotic fluid embolism as pos-
sible underlying causes. Clinical symptomatology
is often inadequate to differentiate between car-
diogenic pulmonary edema and ARDS since the
usual clinical findings are remarkably similar.
The central pathophysiologic feature of ARDS
is increased permeability of the alveolar-capillary
membranes with resultant progressive interstitial
and alveolar edema. The measurement of pulmon-
ary capillary wedge pressure (reflecting left ven-
tricular filling pressure) by a Swan-Ganz balloon
flotation catheter permits to differentiate between
this condition and cardiac causes. In ARDS, al-
though pulmonary arterial pressure and pulmon-
ary vascular resistance may be elevated, the capil-
lary pressure remains normal or low. To our
knowledge this is the first case where the diagnosis
of high permeability pulmonary edema occurring
under tocolytic therapy was firmly established by
simultaneous hemodynamic measurements and
protein analysis of pulmonary edema fluid. Re-
cently there has been another report of ARDS as
a complication of pyelonephritis in pregnancy [5].
Although tocolysis with beta-sympathomimetic
agents was also applied endotoxin mediated injury
of the pulmonary capillaries may have contributed
to the development of ARDS in that case. Animal
studies in which alveolar fluid was obtained by
direct alveolar micropuncture have shown that the
protein concentration of alveolar fluid is similar
to that of fluid in the airways in both cardiac and
permeability types of pulmonary edema [19, 20].
Clinical studies have shown that the analysis of
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edema protein relative to plasma protein concen-
trations is useful in separating these two types of
pulmonary edema. In a study by FEIN et al. [6]
the mean edema fluid to plasma total protein ratio
was 0.94 in patients without clinical or hemody-
namic evidence of cardiovascular disease as
opposed to a mean ratio of 0.46 in patients with
cardiogenic pulmonary edema.
Although our patient received two units of blood
before the onset of dyspnea, we do not see a causal
relation with the development of pulmonary ed-
ema. The improvement of gas exchange and the
clearance of the pulmonary infiltrates were not
preceded or accompanied by a negative fluid bal-
ance. Furthermore, the transfusion of blood
would lead to an expansion of the intravascular
volume with an increase in left ventricular filling
pressure and not to pulmonary capillary leakage.
Pulmonary edema may be induced by blood trans-
fusion as a conseuqence of mechanisms other than
circulatory overload. Immunologie reactions
against granulocytes due to previous sensitization
or by passively transfused antibodies leading to
pulmonary edema have been reported [14, 15].
Careful immuno-hematological work-up of our
patient and the two blood donors had excluded
this possibility.
The hypothesis that at least some of the cases of
pulmonary edema during tocolytic treatment are
due to a transient increase in pulmonary capillary
permeability is supported by the measurement of
normal pulmonary capillary pressure by other in-
vestigators [2, 10]. Furthermore, we have exper-
imental evidence that beta-sympathomimetic de-
crease the carbon monoxide diffusion capacity
in the lungs of healthy volunteers which would
indicate a direct effect on the alveolar-capillary
membranes [16].
The contribution of the various factors like defects
in the alveolar-capillary membrane, fluid over-
load, blood transfusion and corticosteroids for
the development of the full blown clinical picture
of pulmonary edema will vary in different cases.
Abstract
A 26 year old previously healthy woman who was
treated with fenoterol for premature labor at 30 gesta-
tional weeks developed pulmonary edema requiring in-
tubation and mechanical ventilation. Vaginal delivery
was accomplished with forceps after tocolytic therapy
had been stopped. Right heart catheterization with
measurement of pulmonary wedge pressure did not re-
veal left ventricular failure. Protein determination in
lung edema fluid provided evidence of increased pul-
monary capillary permeability. Recovery was rapid and
ventilatory support was stopped after 36 hours. It is
suggested that the infusion of beta-sympathomimetic
drugs may alter the permeability of the alveolar-capillary
membranes which together with triggering factors such
as fluid overload might lead to clinically manifest pul-
monary edema.
Keywords: ARDS, high permeability, pulmonary edema, tocolysis.
Zusammenfassung
Permeabilitätslungenoedem (ARDS) unter tokolytischer
Therapie
Eine 26jährige, vorher gesunde Frau wurde wegen vor-
zeitiger Wehen in der dreißigsten Schwangerschaftswo-
che mit einer Tropfinfusion des beta2-Mimetikums Fe-
noterol behandelt. Wegen der Entwicklung einer respira-
torischen Insuffizienz bei Lungenödem war eine Intuba-
tion und maschinelle Beatmung notwendig. Die tokolyti-
sche Behandlung wurde gestoppt und die Patientin
vaginal mittels Zange entbunden. Der durchgeführte
Rechtsherzkatheter ergab keinen Anhaltspunkt für eine
Linksherz-Insuffizienz. Der hohe Proteingehalt der ab-
gesaugten Lungenödem-Flüssigkeit deutete auf eine er-
höhte Permeabilität der Lungenkapillaren hin. Die Pa-
tientin erholte sich ausgesprochen rasch, so daß sie nach
36 Stunden extubiert werden konnte. Es ist möglich, daß
die Infusion eines betaz-Adrenergikums in der Schwan-
gerschaft die Permeabilität der alveolo-kapillären Mem-
bran erhöht, so daß es vor allem dann, wenn zusätzliche
Momente wie z. B. eine Flüssigkeitsüberladung vorlie-
gen, zum Auftreten eines klinisch manifesten Lungen-
ödems kommen kann.
Schlüsselwörter: ARDS, Lungenödem, Permeabilitätserhöhung.
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Resume
(Edeme pulmonaire ä haute permeabilite (A.R.D.S.) au
cours du traitement tocolytique
Une patiente de 26 ans jusqu'alors en bonne sante,
traitee par du Fenoterol pour une menace d'accouche-
ment premature ä 30 semaines a presente un oedeme
puhnonaire necessitant une intubation et une ventilation
artificielle.Un accouchement par voie basse avec applica-
tion de forceps s'est deroule apres l'arret de la tocolyse.
Un catheterisme droit avec mesure des pressions pulmo-
naires n'a pas mis en evidence de defaillance ventriculaire
gauche. La recherche de proteines dans le liquide d'oe-
deme puhnonaire a apporte la preuve d'une augmenta-
tion de la permeabilite capillaire puhnonaire. La gueri-
son a etc rapide et Fassistance ventilatoire a pü etre
interrompue au bout de 36 heures. Les auteurs suggerent
que la perfusion de beta-2-mimetiques peut alterer la
permeabilite des membranes alveolo-capillaires ce qui
en liaison avec des facteurs declenchants tels qu'une
surcharge liquidienne peut conduire a un oedeme puhno-
naire manifeste cliniquement.
Mots-cles: A.R.D.S., oedeme pulmonaire, permeabilite elevee, tocolyse.
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